The page is the record's research on the issuer — no analyst, no rating, no view. # AgomAb Therapeutics NV (NASDAQ: AGMB) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing AgomAb Therapeutics NV is listed on NASDAQ under ticker AGMB, with ISIN US00860C1027 and LEI not on the record. The record holds its security type as non-operating entity type (other), its segment as not on the record, its sector as 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction as Belgium. The listing status is listed, not halted. ## The disclosure read The record holds 47 filings on 31 filing days in the window from 2025-11-08 to 2026-11-08. By type, 21 are directors' dealings, 3 are prospectuses, 11 are regulatory filings and 12 are results. The median gap between filing days is 7.0 days, against a NASDAQ median of 6.0 days and a sector median of 5.5 days. The latest filing is dated 2026-11-06, a directors' dealings filing, 2 days before the record date. The NASDAQ median latency is 5.0 days and the sector median latency is 4.0 days, and the issuer's median latency is not on the record. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor location is not on the record. The record holds no auditor changes. ## Events and halts The record holds two listing lines, dated 2026-02-03 and 2026-02-05. It holds no delisting and no name change. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted. ## Orderability The outcome is not determinable under rule version acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, as of 2026-11-04, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. No signal code is given. ## Coverage No research houses were found on the investor-relations pages read, and the count is 0. ## Open research No openly published research notes were found on the record, and the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The record holds sealed years 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. The market's vintage is sealed. ## Sources 7 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0002020932.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/AGMB (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/AGMB (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/AGMB · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp